Akili EndeavorOTC

EndeavorOTC is an FDA-cleared over-the-counter digital therapeutic for adults with ADHD, delivered through an engaging video game experience. Unlike the prescription EndeavorRx for children, EndeavorOTC is indicated for adults with primarily inattentive or combined-type ADHD and can be obtained without a prescription. The game uses the same neuroscience-based approach as EndeavorRx, employing sensory stimuli and motor challenges to target brain areas key to attention function. Users navigate courses, collect targets, and avoid obstacles while being challenged to multitask and ignore distractions. FDA cleared in June 2024, EndeavorOTC represents the first OTC digital therapeutic for adult ADHD.